Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety
Mahlangu J, Levy H, Kosinova MV, Khachatryan H, Korczowski B, [...]
An update of the current pharmacotherapeutic armamentarium for hemophilia A
Mahlangu J. An update of the current pharmacotherapeutic armamentarium for [...]
Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections
Maduray K, Parboosing R. Metal Nanoparticles: a Promising Treatment for [...]
Impact of level five lockdown on the incidence of COVID-19: lessons learned from South Africa
Made F, Utembe W, Wilson K, Naicker N, Tlotleng N, [...]
Ten-year risk of fatal cardiovascular disease and its association with metabolic risk factors among waste pickers in South Africa
Made F, Nonterah EA, Tlotleng N, Ntlebi V, Naicker N. [...]
Clinical Characteristics and Histopathology of Coronavirus Disease 2019-Related Deaths in African Children
Mabena FC, Baillie VL, Hale MJ, Thwala BN, Mthembu N, [...]
The effect of freezing and thawing of samples for anti-factor Xa testing for the determination of enoxaparin activity
Louw S, Gounden R, Vaughan J, Ntabeni L, Mayne A, [...]
Derivatives Are Potent against Multiple Life Cycle Stages of Plasmodium falciparum Malaria Parasites
Leshabane M, Dziwornu GA, Coertzen D, Reader J, Moyo P, [...]